Harnessing Extracellular Matrix Biology for Tumor Drug Delivery
Open Access
- 31 January 2021
- journal article
- review article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (2) , 88
Abstract
The extracellular matrix (ECM) plays an active role in cell life through a tightly controlled reciprocal relationship maintained by several fibrous proteins, enzymes, receptors, and other components. It is also highly involved in cancer progression. Because of its role in cancer etiology, the ECM holds opportunities for cancer therapy on several fronts. There are targets in the tumor-associated ECM at the level of signaling molecules, enzyme expression, protein structure, receptor interactions, and others. In particular, the ECM is implicated in invasiveness of tumors through its signaling interactions with cells. By capitalizing on the biology of the tumor microenvironment and the opportunities it presents for intervention, the ECM has been investigated as a therapeutic target, to facilitate drug delivery, and as a prognostic or diagnostic marker for tumor progression and therapeutic intervention. This review summarizes the tumor ECM biology as it relates to drug delivery with emphasis on design parameters targeting the ECM.Keywords
Funding Information
- National Institutes of Health (F31CA213901)
This publication has 132 references indexed in Scilit:
- Therapeutic Targeting of Hyaluronan in the Tumor StromaCancers, 2012
- Molecular Architecture and Function of Matrix AdhesionsCold Spring Harbor Perspectives in Biology, 2011
- Aligned Collagen Is a Prognostic Signature for Survival in Human Breast CarcinomaThe American Journal of Pathology, 2011
- The Collagen FamilyCold Spring Harbor Perspectives in Biology, 2010
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Diffusion of Particles in the Extracellular Matrix: The Effect of Repulsive Electrostatic InteractionsBiophysical Journal, 2010
- The extracellular matrix in development and morphogenesis: A dynamic viewDevelopmental Biology, 2010
- Anticancer Therapeutics: Targeting Macromolecules and Nanocarriers to Hyaluronan or CD44, a Hyaluronan ReceptorMolecular Pharmaceutics, 2008
- The effect of thrombospondin-1 on breast cancer metastasisBreast Cancer Research and Treatment, 2008
- The Hallmarks of CancerCell, 2000